Unnisa, A.; Chettupalli, A.K.; Alazragi, R.S.; Alelwani, W.; Bannunah, A.M.; Barnawi, J.; Amarachinta, P.R.; Jandrajupalli, S.B.; Elamine, B.A.; Mohamed, O.A.;
et al. Nanostructured Lipid Carriers to Enhance the Bioavailability and Solubility of Ranolazine: Statistical Optimization and Pharmacological Evaluations. Pharmaceuticals 2023, 16, 1151.
https://doi.org/10.3390/ph16081151
AMA Style
Unnisa A, Chettupalli AK, Alazragi RS, Alelwani W, Bannunah AM, Barnawi J, Amarachinta PR, Jandrajupalli SB, Elamine BA, Mohamed OA,
et al. Nanostructured Lipid Carriers to Enhance the Bioavailability and Solubility of Ranolazine: Statistical Optimization and Pharmacological Evaluations. Pharmaceuticals. 2023; 16(8):1151.
https://doi.org/10.3390/ph16081151
Chicago/Turabian Style
Unnisa, Aziz, Ananda K. Chettupalli, Reem S. Alazragi, Walla Alelwani, Azzah M. Bannunah, Jameel Barnawi, Padmanabha R. Amarachinta, Suresh B. Jandrajupalli, Badria A. Elamine, Omkalthoum A. Mohamed,
and et al. 2023. "Nanostructured Lipid Carriers to Enhance the Bioavailability and Solubility of Ranolazine: Statistical Optimization and Pharmacological Evaluations" Pharmaceuticals 16, no. 8: 1151.
https://doi.org/10.3390/ph16081151
APA Style
Unnisa, A., Chettupalli, A. K., Alazragi, R. S., Alelwani, W., Bannunah, A. M., Barnawi, J., Amarachinta, P. R., Jandrajupalli, S. B., Elamine, B. A., Mohamed, O. A., & Hussain, T.
(2023). Nanostructured Lipid Carriers to Enhance the Bioavailability and Solubility of Ranolazine: Statistical Optimization and Pharmacological Evaluations. Pharmaceuticals, 16(8), 1151.
https://doi.org/10.3390/ph16081151
